NO147186B - PROCEDURE FOR PREPARING SUBSTITUTED PURINE COMPOUNDS - Google Patents

PROCEDURE FOR PREPARING SUBSTITUTED PURINE COMPOUNDS Download PDF

Info

Publication number
NO147186B
NO147186B NO772959A NO772959A NO147186B NO 147186 B NO147186 B NO 147186B NO 772959 A NO772959 A NO 772959A NO 772959 A NO772959 A NO 772959A NO 147186 B NO147186 B NO 147186B
Authority
NO
Norway
Prior art keywords
mixture
hydroxyethoxymethyl
acid
filtered
added
Prior art date
Application number
NO772959A
Other languages
Norwegian (no)
Other versions
NO147186C (en
NO772959L (en
Inventor
Howard John Schaeffer
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27109837&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO147186(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US05/773,135 external-priority patent/US4146715A/en
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of NO772959L publication Critical patent/NO772959L/en
Publication of NO147186B publication Critical patent/NO147186B/en
Publication of NO147186C publication Critical patent/NO147186C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Description

Foreliggende oppfinnelse angår en fremgangsmåte for The present invention relates to a method for

syntese av substituerte purinforbindelser, da spesielt 9-(2-hydroksyetoksy-metyl)-derivater av purinene 2-amino-adenin og guanin. synthesis of substituted purine compounds, especially 9-(2-hydroxyethoxymethyl) derivatives of the purines 2-amino-adenine and guanine.

9-(2-hydroksyetoksymetyl)-derivatene av puriner har antiviral aktivitet mot forskjellige typer av DNA- ogRNA-virus, The 9-(2-hydroxyethoxymethyl) derivatives of purines have antiviral activity against various types of DNA and RNA viruses,

både i in vitro og in vivo eksperimenter. Spesielt er disse forbindelser aktive som antivirale midler mot adenovirus, så som adenovirus 5 og rhinovirus. De er spesielt aktive som et anti-viralt middel mot vaccinia og herpes virus, så som simplex, both in vitro and in vivo experiments. In particular, these compounds are active as antiviral agents against adenoviruses, such as adenovirus 5 and rhinovirus. They are particularly active as an anti-viral agent against vaccinia and herpes viruses, such as simplex,

zoster og varicella hos pattedyr, og slike virus frembringer sykdommer som herpetic keratitis hos kaniner og herpetic encephalitis hos mus. zoster and varicella in mammals, and such viruses produce diseases such as herpetic keratitis in rabbits and herpetic encephalitis in mice.

Eksempler på 9-(2-hydroksyetoksymetyl)-derivater av Examples of 9-(2-hydroxyethoxymethyl) derivatives of

puriner som viser spesielt god antiviral aktivitet, er 9-(2-hydroksyetoksymetyl)-guanin og 2-amino-9-(2-hydroksyetoksymetyl)-adenin. purines that show particularly good antiviral activity are 9-(2-hydroxyethoxymethyl)-guanine and 2-amino-9-(2-hydroxyethoxymethyl)-adenine.

Det er kjent en rekke fremgangsmåter for fremstilling av 9-(2-hydroksyetoksymetyl)-derivater av purin, f.eks. kan de fremstilles ved å fjerne en beskyttende gruppe fra 2-stillingen på sidekjeden. Alternativt kan de fremstilles ved å omdanne 2-og/eller 6-substituenter på .purinringen til en annen substituent (se britisk patent nr. 1.523.865). A number of methods are known for the production of 9-(2-hydroxyethoxymethyl) derivatives of purine, e.g. they can be prepared by removing a protecting group from the 2-position of the side chain. Alternatively, they can be prepared by converting 2- and/or 6-substituents on the purine ring to another substituent (see British Patent No. 1,523,865).

Man har nå funnet at visse 9-(2-hyrdoksyetoksymetyl)-derivater av puriner kan fremstilles ved en ny og fordelaktig syntesevei. Foreliggende oppfinnelse tilveiebringer således en fremgangsmåte for fremstilling av forbindelser med formel I: It has now been found that certain 9-(2-hyrdoxyethoxymethyl) derivatives of purines can be prepared by a new and advantageous synthesis route. The present invention thus provides a method for the preparation of compounds of formula I:

hvor R er amino eller hydroksy; som innbefatter at man i nærvær av en base hydrolyserer en forbindelse med formel II: 1 2 hvor R er hydroksy eller -NR • 1 2 og X og X er de samme eller forskjellige, og hver kan representere en alkyl eller fenyl-. 2 gruppe, og R er hydrogen eller where R is amino or hydroxy; which includes, in the presence of a base, hydrolyzing a compound of formula II: 1 2 where R is hydroxy or -NR • 1 2 and X and X are the same or different, and each may represent an alkyl or phenyl-. 2 group, and R is hydrogen or

forutsatt at når R er provided that when R is

hydroksy, så er R hydrogen. Når X og X er alkylgrupper, så har de fortrinnsvis fra 1 til 4 karbonatomer, fortrinnsvis er de av samme type og hver representerer en metylgruppe. hydroxy, then R is hydrogen. When X and X are alkyl groups, they preferably have from 1 to 4 carbon atoms, preferably they are of the same type and each represents a methyl group.

Den base som brukes under hydrolysen kan være en vandig eller alkoholisk primær eller sekundær alifatisk amin, et alkoksyd i alkohol, eller en vandig eller et alkoholisk hydroksyd, f.eks. natriumalkoksyd eller hydroksyd, og den foretrukne base er et vandig, primært alifatisk amin, f.eks. vandig metylamin. Av-hengig av den base som brukes, kan hydrolysen utføres ved tempera-turer fra romtemperatur og opp til den temperatur man finner på et dampbad. Generelt er det slik at jo lavere reaksjonstempera-tur, jo lengre vil reaksjonstiden være, men til gjengjeld får man færre sidereaksioner. The base used during the hydrolysis may be an aqueous or alcoholic primary or secondary aliphatic amine, an alkoxide in alcohol, or an aqueous or alcoholic hydroxide, e.g. sodium alkoxide or hydroxide, and the preferred base is an aqueous primary aliphatic amine, e.g. aqueous methylamine. Depending on the base used, the hydrolysis can be carried out at temperatures from room temperature up to the temperature found in a steam bath. In general, the lower the reaction temperature, the longer the reaction time will be, but in return you get fewer side reactions.

Et mellomprodukt med formelen II hvor R er An intermediate of formula II wherein R is

og hvor R<2> er kan fullstendig hydrolyseres i et trinn, f.eks. ved å bruke vandig metylamin. Alternativt og mer fordelaktig, kan mellomproduktet med formel II deacyleres i 2 trinn, i det første trinnet vil man fjerne en enkel gruppe fra 2- og 6-stillingene på purinringen ved mild hydrolyse ved romtemperatur ved at man f.eks. bruker butylamin i en lavere alkohol. Det annet trinn i hydrolysen, dvs. for å fjerne de gjenværende and where R<2> is can be completely hydrolyzed in one step, e.g. using aqueous methylamine. Alternatively and more advantageously, the intermediate product of formula II can be deacylated in 2 steps, in the first step a simple group will be removed from the 2 and 6 positions on the purine ring by mild hydrolysis at room temperature by e.g. uses butylamine in a lower alcohol. The second step in the hydrolysis, i.e. to remove the remaining ones

utføres ved å bruke sterkere baser, performed using stronger bases,

f.eks. vandig metylamin. e.g. aqueous methylamine.

Mellomproduktene med formel II er nye og kan fremstilles ved å omsette guanin eller 2-aminoadenin hvor 2 og 9, eller 2, 6 og 9-stillingene, respektivt er acylert, med en diester av 2-oksa-l,4-butandiol i nærvær av en katalytisk mengde av en sterk syre, f.eks. svovelsyre, sulfonsyre så som p-toluensulfonsyre, metansulfonsyre eller trifluormetansulfonsyre, sul-faminsyre, bis-(p-nitrofenyl)fosfat eller polyfosforsyre. The intermediates of formula II are new and can be prepared by reacting guanine or 2-aminoadenine where the 2 and 9, or 2, 6 and 9 positions, respectively, are acylated, with a diester of 2-oxa-1,4-butanediol in the presence of a catalytic amount of a strong acid, e.g. sulfuric acid, sulfonic acid such as p-toluenesulfonic acid, methanesulfonic acid or trifluoromethanesulfonic acid, sulfamic acid, bis-(p-nitrophenyl)phosphate or polyphosphoric acid.

Det acylerte purin kan på sin side igjen fremstilles ved The acylated purine can in turn be produced by

å omsette et passende purin med et syreanhydrid så som edikksyreanhydrid, eller et annet acyleringsmiddel, f.eks. et syrehalogenid. reacting a suitable purine with an acid anhydride such as acetic anhydride, or another acylating agent, e.g. an acid halide.

For å fremstille diesteren av 2-oksa-l,4-butandiol, To prepare the diester of 2-oxa-1,4-butanediol,

kan dioksolan omsettes med et syreanhydrid i nærvær av en katalytisk mengde av en sterk syre, f.eks. av den type som er angitt ovenfor. dioxolane can be reacted with an acid anhydride in the presence of a catalytic amount of a strong acid, e.g. of the type specified above.

De følgende eksempler illustrerer oppfinnelsen. The following examples illustrate the invention.

Eksempel 1 - 9-( 2- hydroksyetoksymetyl) guanin Example 1 - 9-(2-hydroxyethoxymethyl)guanine

En blanding av 120 g edikksyreanhydrid, 15 g edikksyre og 5,0 g p-toluensulfonsyre ble avkjølt til 10°C, og 70 g dioksolan ble tilsatt under røring og avkjøling ved en slik hastighet at temperaturen i blandingen ikke oversteg 40°C. Blandingen ble så avkjølt til romtemperatur, og 300 ml toluen og 50 g diacetylguanin ble tilsatt. Reaksjonsblandingen ble så oppvarmet til koking under tilbakeløp i 16 timer. Den ble så avkjølt til romtemperatur og 50 ml kloroform ble tilsatt og det faste produkt fjernet ved filtrering. Filterkaken ble vasket med kloroform og tørket for.dannelse av 2-acetamido-9-(2-acetoksymetyl)hypo-xantin. Den tørkede filterkaken ble tilsatt 350 ml 40% vandig metylamin, og blandingen oppvarmet under koking med tilbakeløp i 40 minutter, så avkjølt og filtrert. Filtratet ble fordampet under redusert trykk til en tykk suspensjon. Denne ble avkjølt og filtrert og filterkaken ble vasket med etanol og tørket, hvorved man fikk 27 g 9-(2-hydroksyetoksymetyl)guanin, renhet større enn 90%, smeltepunkt 255-257°C, utbyttet = 56%. A mixture of 120 g of acetic anhydride, 15 g of acetic acid and 5.0 g of p-toluenesulfonic acid was cooled to 10°C, and 70 g of dioxolane was added with stirring and cooling at such a rate that the temperature of the mixture did not exceed 40°C. The mixture was then cooled to room temperature, and 300 ml of toluene and 50 g of diacetylguanine were added. The reaction mixture was then heated to reflux for 16 hours. It was then cooled to room temperature and 50 ml of chloroform was added and the solid product removed by filtration. The filter cake was washed with chloroform and dried to give 2-acetamido-9-(2-acetoxymethyl)hypoxanthine. The dried filter cake was added to 350 ml of 40% aqueous methylamine, and the mixture heated under reflux for 40 minutes, then cooled and filtered. The filtrate was evaporated under reduced pressure to a thick suspension. This was cooled and filtered and the filter cake was washed with ethanol and dried, thereby obtaining 27 g of 9-(2-hydroxyethoxymethyl)guanine, purity greater than 90%, melting point 255-257°C, yield = 56%.

Eksempel 2 - 9-( 2- hydroksyetoksymetyl) guanin Example 2 - 9-(2-hydroxyethoxymethyl)guanine

En blanding av 50 g diacetylguanin, 59,8 g 2-oksa-l,4-butandiol og 1,2 g p-toluensulfonsyre i 350 ml toluen ble oppvarmet under røring og koking med tilbakeløp i 16 timer. Blandingen ble avkjølt til romtemperatur, filtrert hvoretter filterkaken ble vasket med toluen for dannelse av 2-acetamido-9-(2-ace-toksyetoksymetyl)-hypoxantin. Den ble så tørket og tilsatt 350 ml 40% vandig metylamin. Blandingen ble oppvarmet under koking med tilbakeløp i 40 minutter, avkjølt til romtemperatur og filtrert. Filtratet ble fordampet under redusert trykk til en tykk suspensjon. Denne ble tilsatt 200 ml etanol og det hele ble avkjølt, filtrert og vasket med etanol og tørket, hvorved man fikk 36 g 9-(2-hydroksyetoksymetyl)guanin, mer en 90% rent, utbyttet = 75%. A mixture of 50 g of diacetylguanine, 59.8 g of 2-oxa-1,4-butanediol and 1.2 g of p-toluenesulfonic acid in 350 ml of toluene was heated with stirring and refluxed for 16 hours. The mixture was cooled to room temperature, filtered, after which the filter cake was washed with toluene to give 2-acetamido-9-(2-ace-toxyethoxymethyl)-hypoxanthine. It was then dried and 350 ml of 40% aqueous methylamine was added. The mixture was heated under reflux for 40 minutes, cooled to room temperature and filtered. The filtrate was evaporated under reduced pressure to a thick suspension. To this was added 200 ml of ethanol and the whole was cooled, filtered and washed with ethanol and dried, thereby obtaining 36 g of 9-(2-hydroxyethoxymethyl)guanine, more than 90% pure, yield = 75%.

Eksempel 3 - 2- acetamido- 9-( 2- acetyloksyetoksymetyl) hypozantin Example 3 - 2-acetamido-9-(2-acetyloxyethoxymethyl) hypozantine

( fremstilling av utgangsmateriale) (production of starting material)

En blanding av 1,0 g diacetylguanin, 0,82 g 2-oksa-l,4-butandioldiacetat og 23 mg p-toluensulfonsyre i 4 g mineralolje ble holdt på 115°C under omrøring med redusert trykk over natten. Mineraloljen.ble så avhelt. Resten ble behandlet med kloroform og så ekstrahert med kokende metanol. Metanolekstraktet ble konsentrert til 50 ml, avkjølt og filtrert. Filtratet ble fordampet til tørrhet, hvorved man fikk 0,43 g faststoff. Dette ble renset ved kolonnekromatografi (silisiumdioksydgel, 10 g i kloroform eluert med 1:1 kloroform:aceton), hvoretter man fikk en omkrystallisering fra etanol og fikk 0,14 g 2-acetamido-9-(2-acetyloksyetoksymetyl)hypoxantin, smeltepunkt 202,5-204,5°C. A mixture of 1.0 g of diacetylguanine, 0.82 g of 2-oxa-1,4-butanediol diacetate and 23 mg of p-toluenesulfonic acid in 4 g of mineral oil was kept at 115°C under reduced pressure stirring overnight. The mineral oil was then poured off. The residue was treated with chloroform and then extracted with boiling methanol. The methanol extract was concentrated to 50 ml, cooled and filtered. The filtrate was evaporated to dryness, whereby 0.43 g of solid was obtained. This was purified by column chromatography (silica gel, 10 g in chloroform eluted with 1:1 chloroform:acetone), after which a recrystallization from ethanol gave 0.14 g of 2-acetamido-9-(2-acetyloxyethoxymethyl)hypoxanthine, melting point 202, 5-204.5°C.

Eksempel 4 - 2- amino- 9-( 2- hydroksyetoksymetyl) adenin Example 4 - 2-amino-9-(2-hydroxyethoxymethyl)adenine

(a) 89,0 g 2-formamidoadenin ble plassert i en 5-liters kolbe utstyrt med en luftrører og en kjøler (CaCl2"tørkerør) som var tilsatt 4 1 edikksyreanhydrid. Blandingen ble kokt ved tilbake-løp og holdt under koking i 60 timer. Deretter ble overskuddet av anhydrid fjernet ved destillasjon ved atmosfæres trykk inntil man hadde fjernet ca. 3,5 1 destillat. Destillasjonen under redusert trykk ble fortsatt til man hadde fjernet mesteparten av (a) 89.0 g of 2-formamidoadenine was placed in a 5-liter flask equipped with an air stirrer and a condenser (CaCl2" drying tube) to which was added 4 L of acetic anhydride. The mixture was refluxed and kept under reflux for 60 hours. Then the excess of anhydride was removed by distillation at atmospheric pressure until about 3.5 liters of distillate had been removed. Distillation under reduced pressure was continued until most of the

det gjenværende anhydrid. Det mørke brune residuet var viskøst ved avkjøling til romtemperatur og ble oppløst i diklormetan. the remaining anhydride. The dark brown residue was viscous on cooling to room temperature and was dissolved in dichloromethane.

Det ble filtrert for å fjerne suspenderte faste stoffer, hvoretter oppløsningen ble fordampet i vakuum og man fikk 211,0 g (> 100%) av 2,6-bis-(diacetylamino)-9-acetylpurin. Utbyttet var 96,7% basert på nmr, og resten av materialet var edikksyreanhydrid. (b) 174 g penta-acetylpurin ble slått sammen med en 126,8 g 1,4-diacetoksy-2-oksabutan i en kolbe utstyrt med rører og tørke-rør. Blandingen ble plassert på et oljebad ved 130°C og rørt i et par minutter for å homogenisere blandingen. Syrekatalysatoren, dvs. 2,74 g para-toluensulfonsyre ble så tilsatt i en porsjon og oppvarmingen ble fortsatt i vakuum i 4 timer hvorved man da fikk en nesten kvantitativ omdannelse til produktene. Reaksjonsblandingen ble avkjølt til romtemperatur og lagret under tørr nitrogen. (c) Smelteproduktet (208,5 g) ble oppløst i etanol (5 ml/g) ved romtemperatur og overført til en kolbe utstyrt med en dråpe-trakt, rører og termometer. 14 0,4 g n-butylamin ble så dråpvis tilsatt iløpet av 2 timer, og den eksotermiske reaksjonen ble regulert ved hjelp av et vannbad. Maksimumstemperaturen som tillot reaksjonen gå til,var bare ca. 30°C. Produktet begynte å skille seg ut fra blandingen under selve tilsetningen. Etter at tilsetningen var ferdig, ble blandingen rørt ved romtemperatur i 3 timer og så plassert i et kaldt rom over natten. Produktet ble fjernet ved filtrering og man fikk en pasta-lignende masse som ble utrørt med 1 x 500 ml aceton og så igjen filtrert. Produktet ble tørket i vakuum ved 65°C i 3 timer og så ved romtemperatur over natten hvorved man fikk 154,2 g (91,7%) av et lyst brunt hardt fast stoff. Dette produkt ble renset ved at det ble oppløst i varm dimetylformamid (10 ml/g) ved 100-110°C slik at man fikk en ugjennomskinnelig brun oppløsning. Etter avkjøling over natten ved 5°C, ble produktet fjernet ved filtrering, vasket med 1 x 250 ml aceton og lufttørket, hvorved man fikk 121,7 g (78,8%) 2,6-diacetamido-9-(2-acetoksyetoksymetyl)purin. (d) 121,7 g 2,6-diacetamido-9-(2-acetoksyetoksymetyl)purin ble tilsatt en rørt oppløsning av vandig metylamin (608,5 ml av en 40% oppløsning) iløpet av 5 minutter. Tilsetningen ble fulgt av en mild eksotermisk reaksjon som hevet temperaturen på blandingen til 35°C og alt faststoff løste seg iløpet av et par minutter. Etter røring i 2 1/2 time, viste tynnsjiktskromato-grafi av blandingen at man hadde en fullstendig reaksjon. Blandingen ble så konsentrert i vakuum på et vannbad ved 4 5-50°C og man fikk en tykk masse av brune krystaller. Disse ble ut-rørt med 545 ml aceton i et kvarter for å fjenre N-metylacetamid og deretter vakuumfiltrert. Filterkaken ble vasket med aceton (1 x 200 ml) og lufttørket, hvorved man fikk 74,7 g (96,0%) It was filtered to remove suspended solids, after which the solution was evaporated in vacuo to give 211.0 g (> 100%) of 2,6-bis-(diacetylamino)-9-acetylpurine. The yield was 96.7% based on nmr, and the rest of the material was acetic anhydride. (b) 174 g of penta-acetylpurine was combined with 126.8 g of 1,4-diacetoxy-2-oxabutane in a flask equipped with a stirrer and drying tube. The mixture was placed in an oil bath at 130°C and stirred for a few minutes to homogenize the mixture. The acid catalyst, i.e. 2.74 g of para-toluenesulfonic acid, was then added in one portion and the heating was continued in vacuum for 4 hours, whereby an almost quantitative conversion to the products was then obtained. The reaction mixture was cooled to room temperature and stored under dry nitrogen. (c) The melt product (208.5 g) was dissolved in ethanol (5 ml/g) at room temperature and transferred to a flask equipped with a dropping funnel, stirrer and thermometer. 14 0.4 g of n-butylamine was then added dropwise over 2 hours, and the exothermic reaction was regulated by means of a water bath. The maximum temperature that allowed the reaction to proceed was only approx. 30°C. The product began to separate from the mixture during the actual addition. After the addition was complete, the mixture was stirred at room temperature for 3 hours and then placed in a cold room overnight. The product was removed by filtration and a paste-like mass was obtained which was stirred with 1 x 500 ml of acetone and then filtered again. The product was dried in vacuo at 65°C for 3 hours and then at room temperature overnight to give 154.2 g (91.7%) of a light brown hard solid. This product was purified by dissolving it in hot dimethylformamide (10 ml/g) at 100-110°C to give an opaque brown solution. After cooling overnight at 5°C, the product was removed by filtration, washed with 1 x 250 mL of acetone and air dried to give 121.7 g (78.8%) of 2,6-diacetamido-9-(2-acetoxyethoxymethyl ) purine. (d) 121.7 g of 2,6-diacetamido-9-(2-acetoxyethoxymethyl)purine was added to a stirred solution of aqueous methylamine (608.5 ml of a 40% solution) over 5 minutes. The addition was followed by a mild exothermic reaction which raised the temperature of the mixture to 35°C and all solids dissolved within a few minutes. After stirring for 2 1/2 hours, thin layer chromatography of the mixture showed complete reaction. The mixture was then concentrated in vacuo on a water bath at 45-50°C and a thick mass of brown crystals was obtained. These were stirred with 545 ml of acetone for fifteen minutes to remove N-methylacetamide and then vacuum filtered. The filter cake was washed with acetone (1 x 200 ml) and air dried, whereby 74.7 g (96.0%) were obtained

uren hydrert 2-amino-9-(2-hydroksyetoksymetyl)adenin som lyst brune krystaller. Disse ble tørket i vakuum ved 80°C i 18 timer, og man fikk 69,3 g (89,0%) tørt produkt. impure hydrogenated 2-amino-9-(2-hydroxyethoxymethyl)adenine as light brown crystals. These were dried in vacuum at 80°C for 18 hours, and 69.3 g (89.0%) of dry product was obtained.

Eksempel 5 Example 5

2-acetamido-9-(2-acetyloksyetoksymetyl)hypoxantin (6,19 g) ble suspendert i IN natriumhydroksyd (40 ml) og oppvarmet ved tilbakeløp i 1 time. Blandingen ble avkjølt, nøytralisert med 6N saltsyre og produktet frafiltrert. Det faste stoffet ble vasket med isvann (10 ml) og med aceton (15 ml) og tørket under vakuum natten over. Vekt 4,13 g (91,8%) av 9-(2-hydroksyetoksymetyl) guanin, smp. 255-257°C. 2-acetamido-9-(2-acetyloxyethoxymethyl)hypoxanthine (6.19 g) was suspended in 1N sodium hydroxide (40 mL) and heated at reflux for 1 hour. The mixture was cooled, neutralized with 6N hydrochloric acid and the product filtered off. The solid was washed with ice water (10 mL) and with acetone (15 mL) and dried under vacuum overnight. Weight 4.13 g (91.8%) of 9-(2-hydroxyethoxymethyl)guanine, m.p. 255-257°C.

Eksempel 6 Example 6

2-acetamido-9-(2-acetyloksyetoksymetyl)hypoxantin 2-acetamido-9-(2-acetyloxyethoxymethyl)hypoxanthine

(6,19 g) ble oppslemmet i en oppløsning av natriummetylat (3,24 g) i metanol (40 ml). Blandingen ble oppvarmet ved til-bakeløp i 1 time og fikk avkjøles. Iseddik (3,96 g) ble tilsatt og blandingen helt i vann (40 ml). Etter avkjøling, (6.19 g) was slurried in a solution of sodium methylate (3.24 g) in methanol (40 ml). The mixture was heated at reflux for 1 hour and allowed to cool. Glacial vinegar (3.96 g) was added and the mixture poured into water (40 ml). After cooling,

0°C, ble det resulterende bunnfall filtrert, vasket med kaldt vann (15 ml) og med aceton (15 ml) og tørket under vakuum og dette ga 4,03 g (89,6%) 9-(2-hydroksyetoksymetyl)guanin, 0°C, the resulting precipitate was filtered, washed with cold water (15 mL) and with acetone (15 mL) and dried under vacuum to give 4.03 g (89.6%) of 9-(2-hydroxyethoxymethyl)guanine ,

smp. 255-257°C. m.p. 255-257°C.

Eksempel 7 Example 7

2-acetamido-9- (2-acetyloksyetoksymetyl)hypoxantin 2-acetamido-9-(2-acetyloxyethoxymethyl)hypoxanthine

(6,19 g) ble tilsatt til en oppløsning av kaliumhydroksyd (3,96 g) i etanol (40 ml) og oppvarmet ved tilbakeløp i 1 (6.19 g) was added to a solution of potassium hydroxide (3.96 g) in ethanol (40 mL) and heated at reflux for 1

time. Blandingen fikk avkjøles og iseddik (3,96 g ) ble tilsatt. Blandingen ble helt i vann (40 ml) og 50 ml vann ble tilsatt. pH-verdien ble innstilt til 7,0 med vandig natriumhydroksyd og blandingen avkjølt med is-vann og filtrert. Det faste stoffet vasket med kaldt vann (20 ml) og med aceton (20 ml) hour. The mixture was allowed to cool and glacial acetic acid (3.96 g) was added. The mixture was poured into water (40 ml) and 50 ml of water was added. The pH was adjusted to 7.0 with aqueous sodium hydroxide and the mixture cooled with ice-water and filtered. The solid washed with cold water (20 ml) and with acetone (20 ml)

og tørket under vakuum og dette ga 4,0 g (88,9%) 9-(2-hydroksyetoksymetyl) guanin, smp. 255-257°C. and dried under vacuum to give 4.0 g (88.9%) of 9-(2-hydroxyethoxymethyl)guanine, m.p. 255-257°C.

Eksempel 8 Example 8

2-acetamido-9-(2-acetyloksyetoksymetyl)hypoxantin 2-acetamido-9-(2-acetyloxyethoxymethyl)hypoxanthine

(6,19 g) ble oppslemmet med trietylamin (5 g) og vann (40 ml) og blandingen oppvarmet ved tilbakeløp i 2 timer. Blandingen fikk avkjøles til 0°C og ble filtrert. Det faste stoffet ble vasket med vann (15 ml) og med aceton (15 ml) og tørket under vakuum og dette ga 4,34 g (96%) 9-(2-hydroksyetoksymetyl)guanin, smp. 255-257°C. (6.19 g) was slurried with triethylamine (5 g) and water (40 mL) and the mixture heated at reflux for 2 h. The mixture was allowed to cool to 0°C and was filtered. The solid was washed with water (15 ml) and with acetone (15 ml) and dried under vacuum to give 4.34 g (96%) of 9-(2-hydroxyethoxymethyl)guanine, m.p. 255-257°C.

Claims (2)

1. Fremgangsmåte for fremstilling av forbindelser med formel I: hvor R er amino eller hydroksy, karakterisert ved at man i nærvær av en base hydrolyserer en forbindelse med formel II: hvor R"*" er hydroksy eller 1 2 og X og X er de samme eller forskjellige og hver kan representere en alkyl eller 2 fenylgruppe, og R er hydrogen eller forutsatt at når R er hydroksy, så er R <2>hydrogen.1. Process for the preparation of compounds of formula I: where R is amino or hydroxy, characterized in that a compound of formula II is hydrolysed in the presence of a base: where R"*" is hydroxy or 1 2 and X and X are the same or different and each may represent an alkyl or 2 phenyl group, and R is hydrogen or provided that when R is hydroxy, then R <2>hydrogen. 2. Fremgangsmåte ifølge krav 1, karakterisert ved at det som base anvendes et vandig eller alkoholisk, primært eller sekundært alifatisk amin, et alkoksyd i alkohol eller et vandig eller alkoholisk hydroksyd.2. Method according to claim 1, characterized in that an aqueous or alcoholic, primary or secondary aliphatic amine, an alkoxide in alcohol or an aqueous or alcoholic hydroxide is used as the base.
NO772959A 1976-08-27 1977-08-26 PROCEDURE FOR PREPARING SUBSTITUTED PURINE COMPOUNDS NO147186C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71810576A 1976-08-27 1976-08-27
US05/773,135 US4146715A (en) 1975-08-27 1977-02-28 2-amido-9-(2-acyloxyethoxymethyl)hypoxanthines

Publications (3)

Publication Number Publication Date
NO772959L NO772959L (en) 1978-02-28
NO147186B true NO147186B (en) 1982-11-08
NO147186C NO147186C (en) 1983-02-16

Family

ID=27109837

Family Applications (2)

Application Number Title Priority Date Filing Date
NO772959A NO147186C (en) 1976-08-27 1977-08-26 PROCEDURE FOR PREPARING SUBSTITUTED PURINE COMPOUNDS
NO822502A NO150119C (en) 1976-08-27 1982-07-20 INTERMEDIATES FOR USE IN THE PREPARATION OF SUBSTITUTED PURINE COMPOUNDS

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO822502A NO150119C (en) 1976-08-27 1982-07-20 INTERMEDIATES FOR USE IN THE PREPARATION OF SUBSTITUTED PURINE COMPOUNDS

Country Status (12)

Country Link
AT (1) AT357566B (en)
CA (2) CA1096863A (en)
CH (1) CH634843A5 (en)
CS (1) CS196384B2 (en)
DD (1) DD131856A6 (en)
DK (1) DK147857C (en)
FI (1) FI64160C (en)
GB (1) GB1567671A (en)
NL (1) NL7709458A (en)
NO (2) NO147186C (en)
SE (2) SE432764B (en)
YU (1) YU41079B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880820A (en) * 1983-06-24 1989-11-14 Merck & Co., Inc. Guanine derivatives
US4918219A (en) * 1983-10-31 1990-04-17 Warner-Lambert Company Glycerine derivatives
IE842642L (en) * 1983-10-31 1985-04-30 Harvard College Purine Derivatives
YU45690B (en) * 1984-12-22 1992-07-20 Krka Tovarna Zdraviln.Sol.O. PROCEDURE FOR PREPARING 9- (2-HYDROXYETHOXYMETHYL) -GUANINE
DE3889248T2 (en) * 1987-05-04 1994-11-17 Kemijski Inst Process for the preparation of purine compounds.
EP0717744B1 (en) * 1993-09-10 1997-05-07 RECORDATI S.A. CHEMICAL and PHARMACEUTICAL COMPANY A process for the preparation of 9-(2-hydroxy)-ethoxymethyl-guanine
DE19536164A1 (en) * 1995-09-28 1997-04-03 Boehringer Ingelheim Kg Improved Process for the Production of 9 - [(2-Hydroxyethoxy) methyl] guanine (Acyclovir)
IT1276126B1 (en) * 1995-11-14 1997-10-27 Archimica Spa PROCEDURE FOR THE PREPARATION OF 9 - ((2-HYDROXYETHOXY) METHYL) GUANINE
WO1997024357A1 (en) * 1995-12-28 1997-07-10 Mallinckrodt Chemical, Inc. Process for synthesis and purification of a compound useful in the preparation of acyclovir

Also Published As

Publication number Publication date
CA1096864A (en) 1981-03-03
SE447113B (en) 1986-10-27
SE7709606L (en) 1978-02-28
DK380377A (en) 1978-02-28
FI772548A (en) 1978-02-28
NO147186C (en) 1983-02-16
NO150119C (en) 1984-08-22
FI64160B (en) 1983-06-30
CS196384B2 (en) 1980-03-31
ATA620177A (en) 1979-12-15
YU202277A (en) 1983-02-28
CA1096863A (en) 1981-03-03
NL7709458A (en) 1978-03-01
SE8304549L (en) 1983-08-23
YU41079B (en) 1986-12-31
NO150119B (en) 1984-05-14
CH634843A5 (en) 1983-02-28
SE432764B (en) 1984-04-16
FI64160C (en) 1983-10-10
DK147857C (en) 1985-06-10
NO772959L (en) 1978-02-28
DD131856A6 (en) 1978-07-26
SE8304549D0 (en) 1983-08-23
NO822502L (en) 1978-02-28
GB1567671A (en) 1980-05-21
AT357566B (en) 1980-07-25
DK147857B (en) 1984-12-24

Similar Documents

Publication Publication Date Title
EP1883639B1 (en) Preparation of famciclovir and other purine derivatives
CA2188181C (en) Preparation of purines
NO152446B (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 9-SUBSTITUTED HYPOXANTIN DERIVATIVES
NO147186B (en) PROCEDURE FOR PREPARING SUBSTITUTED PURINE COMPOUNDS
AU613967B2 (en) Process for the preparation of purine derivatives
US3501456A (en) Arabinofuranosyl nucleosides and intermediates
CA1075237A (en) Purine derivatives
Kaiwar et al. Synthesis of 9-[cis-3-(hydroxymethyl) cyclobutyl]-adenine and-guanine
SU1454253A3 (en) Method of producing 9-(2-oxyethoxymethyl) guanine
US6646125B1 (en) Process for the synthesis of chloropurine intermediates
SU932991A3 (en) Process for producing purine derivatives
EP0052959B1 (en) Production of purine derivatives and intermediates therefor
CA1296001C (en) 1-hydroxyalkylxanthines, processes for their preparation and medicaments containing them
CN109206465B (en) Method for synthesizing adenosine cyclophosphate
PL108512B1 (en) Method of producing purine derivatives
Detweiler et al. Some Heterocyclic Secondary Amines1
RU1809831C (en) Method of dideoxynucleosides synthesis
US3317532A (en) Derivatives of pyrimidine
Baker et al. Synthesis of 6‐substituted pyrimidines by the wittig reaction. III. Via 2‐amino‐4‐hydroxy‐5‐phenylbutyl‐6‐pyrimidylmethyl triphenyl phosphonium bromide
Doak et al. The reaction between diazonium fluoborates and antimony trichloride in organic solvents
DK142323B (en) Process for the preparation of pyrimido (4,5-b) quinoline-4 (3H) -one-2-carboxylic acid alkyl esters.
Ghal et al. An Efficient Synthesis of 2-[(4-Amino∼ 1, 2-dihyro-2-oxo-1-pyrimidinyl) methoxyi-l, 3-propanediyl-di-L-valinate an Anti-cytomegalovirus Agent
JPS5913800A (en) Preparation of 9-(beta-d-arabinofuranosyl)adenine
MXPA97005480A (en) Procedure to prepare penciclovir or famciclo
JPH03240788A (en) New production of cyclobutane derivative and intermediate